Michael G. Knell serves as Senior Vice President, Chief Accounting Officer, and Interim Chief Financial Officer at Charles River Laboratories International, Inc., a global leader in drug discovery and development services. With over 25 years of experience in finance and accounting, Knell joined Charles River in 2006 as Director of Technical Accounting after spending a decade at Deloitte & Touche LLP, where he specialized in audit services for life sciences and healthcare clients. A Certified Public Accountant licensed in Massachusetts, he holds a Bachelor of Science in Accounting from Bentley University and has been instrumental in strengthening the company's financial infrastructure amid rapid growth and regulatory changes. Throughout his tenure at Charles River, Knell has advanced through key leadership roles, including Vice President of Accounting and Controller, overseeing global financial reporting, internal controls, and compliance with SEC requirements and Sarbanes-Oxley standards. His achievements include leading the successful integration of financial systems during multiple acquisitions, enhancing operational efficiency, and supporting the company's expansion into new therapeutic areas. Under his guidance, Charles River has maintained exemplary financial transparency, contributing to consistent revenue growth and investor confidence. As Interim CFO, Knell now directs a broad spectrum of financial operations, including strategic planning, treasury, tax, and investor relations, while continuing to champion accounting excellence. His strategic foresight has been pivotal in navigating economic challenges and positioning Charles River for sustained innovation in the biopharmaceutical sector.